Offer - Urjas Oil for just ₹ 1 X
Tamlocept 0.4 Capsule PR is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Male) |
|
Geriatric |
|
Is the use of Tamlocept 0.4 Capsule PR safe for pregnant women?
No research has not been done till date on the safety of Tamlocept for pregnant women. So its effects on pregnant women are unknown.
Is the use of Tamlocept 0.4 Capsule PR safe during breastfeeding?
There is no research available on the side effects of Tamlocept in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Tamlocept 0.4 Capsule PR on the Kidneys?
Tamlocept does not damage the kidneys.
What is the effect of Tamlocept 0.4 Capsule PR on the Liver?
Tamlocept is completely safe for the liver.
What is the effect of Tamlocept 0.4 Capsule PR on the Heart?
Using Tamlocept does not have any harmful effects on the heart.
Tamlocept 0.4 Capsule PR should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tamlocept 0.4 Capsule PR unless your doctor advises you to do so -
Is this Tamlocept 0.4 Capsule PR habit forming or addictive?
No, you will not get addicted to Tamlocept 0.4 Capsule PR.
Is it safe to drive or operate heavy machinery when consuming?
Tamlocept 0.4 Capsule PR will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Tamlocept 0.4 Capsule PR is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Tamlocept 0.4 Capsule PR cannot treat any kind of mental disorder.
Interaction between Food and Tamlocept 0.4 Capsule PR
It is safe to take Tamlocept 0.4 Capsule PR with food.
Interaction between Alcohol and Tamlocept 0.4 Capsule PR
Consult your doctor before consuming alcohol while taking Tamlocept 0.4 Capsule PR as it can have severe side effects.
No, Tamlocept is not a diuretic. It is rather an alpha-blocker that relaxes the prostate and bladder neck, making it easier to urinate.
Tamlocept is a brand name for tamsulosin. It belongs to a class of drugs known as alpha blockers. It is available in the form of a tablet and capsule. It is used in men for the treatment of enlarged prostate (benign prostate hyperplasia or BPH) which may comprise painful urination, difficulty in urinating (incomplete bladder emptying, hesitation, dribbling, weak stream), urgency and frequency. It is also used for the treatment of chronic prostatitis (off-label).
Yes, Tamlocept has the potential to lower the blood pressure and cause hypotension. Low blood pressure can be avoided or managed by drinking lots of fluids, taking food rich in B12 and folate, taking adequate salt, and by taking caffeine.
Rarely, Tamlocept causes a persistent painful penile erection which is not related to an intercourse. This condition is known as priapism. If not treated properly, this condition can cause permanent impotence. Therefore, if you suffer from any such condition while taking Tamlocept, please inform your doctor immediately.
Tamlocept blocks receptors in the prostate, prostatic capsule, prostate urethra, and bladder neck. When these receptors are blocked, smooth muscle relaxation occurs in the bladder neck and prostate, decreasing the urinary outflow resistance in men.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flomax® (tamsulosin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142-143
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1172-1173